COVID-19 Vaccine Compatible with Trial Testing of Rett Gene Therapy

COVID-19 Vaccine Compatible with Trial Testing of Rett Gene Therapy

290849

COVID-19 Vaccine Compatible with Trial Testing of Rett Gene Therapy

People with Rett syndrome can receive the COVID-19 vaccine from Johnson & Johnson and still participate in future clinical trials of the investigational gene therapy TSHA-102, the treatment’s developer has announced. “We are aware of concerns about the adenovirus vector COVID-19 vaccine from Johnson & Johnson (J&J) and its potential impact on eligibility to receive an investigational gene therapy in the future,” Taysha Gene Therapies wrote in a statement published by Reverse Rett. “However, available evidence…

You must be logged in to read/download the full post.